Welcome
Support Centre
14 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Feasibility of abdominal massage for the alleviation of the symptoms of constipation in people with multiple sclerosis
ISRCTN ISRCTN01328898
ClinicalTrials.gov identifier
Public title Feasibility of abdominal massage for the alleviation of the symptoms of constipation in people with multiple sclerosis
Scientific title A randomised controlled pilot study to assess the feasibility of abdominal massage for the alleviation of the symptoms of constipation in people with multiple sclerosis
Acronym ABMIMS
Serial number at source 08/NIR02/80
Study hypothesis Abdominal massage will relieve some of the symptoms of constipation in people with multiple sclerosis.
Ethics approval Office for Research Ethics Committees Northern Ireland (ORECNI) 25th September 2008 (ref: 08/NIR02/80)
Study design Pilot study, two-group randomised controlled clinical trial
Countries of recruitment United Kingdom
Disease/condition/study domain Multiple sclerosis
Participants - inclusion criteria 1. Constipation as defined by the Rome II criteria
2. Age range over 18 years, male or female
Participants - exclusion criteria 1. Bowel cancer
2. Stoma
3. Abdominal surgery (inside last year)
Anticipated start date 01/11/2008
Anticipated end date 01/11/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 30
Interventions Following expressing an interest in the study, potential participants will be provided with verbal and written information concerning their involvement and informed consent will be obtained. Providing screening is satisfactory, participants will then be randomly allocated to a treatment and a control group. Baseline outcome measures will be undertaken at this point by a research assistant who will be blind to group allocation:
1. Constipation Scoring System
2. Neurogenic Bowel Dysfunction Score
3. Bowel Diary
4. 29-item Multiple Sclerosis Impact Scale (MSIS-29)
5. Qualiveen Questionnaire

The intervention group will then be visited in their own home, provided with advice on good bowel habits and they and/or their carers will be shown how to undertake abdominal massage. This will be undertaken daily for 15 minutes for 4 weeks. A DVD demonstrating the technique will be left, and they will be visited at least once a week by the clinician to provide further training and support.

The control group will be visited in their own home and provided with advice on good bowel habits. This group will be visited once a week for 4 weeks.
Primary outcome measure(s) Constipation scoring system, undertaken at the end of the intervention period (week 4) and 4 weeks later (week 8).
Secondary outcome measure(s) 1. Neurogenic Bowel Dysfunction Score
2. Bowel Diary
3. Qualiveen Questionnaire
4. 29-item Multiple Sclerosis Impact Scale (MSIS-29)

Outcome measures will be undertaken at the end of the intervention period (week 4) and 4 weeks later (week 8).
Sources of funding Multiple Sclerosis Trust (UK)
Trial website
Publications
Contact name Dr  Doreen  McClurg
  Address Nursing Midwifery and Allied Health Professions Research Unit (NMAHPRU)
Glasgow Caledonian University
Buchanan House
  City/town Glasgow
  Zip/Postcode G4 0BA
  Country United Kingdom
  Tel +44 (0)141 331 8105
  Email Doreen.mclurg@gcal.ac.uk
Sponsor Nursing Midwifery and Allied Health Professions Research Unit (UK)
  Address Glasgow Caledonian University
Buchanan House
  City/town Glasgow
  Zip/Postcode G4 OBA
  Country United Kingdom
  Sponsor website: http://www/nmahpru.gcal.ac.uk
Date applied 19/11/2008
Last edited 06/01/2009
Date ISRCTN assigned 05/01/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central